| № |
Test |
Drug Resistance |
Sample |
Result |
| 1 |
EGFR |
Erlotinib (Tarceva)Gefitinib (İressa) |
Tumor tissue / paraffin block |
7-14 days |
| 2 |
KRAS |
Erbitux(Cetuximab)Vectibix (Panitumumab) |
Tumor tissue / paraffin block |
7-14 days |
| 3 |
BRAF |
Erbitux(Cetuximab)Vectibix (Panitumumab) |
Tumor tissue / paraffin block |
7-14 days |
| 4 |
PIK3CA |
Trastuzumab (Herceptin™), Cetuximab (Erbitux™), Panitumumab (Vectibix™) Lapatinib (Tyverb/Tykerb™) |
Tumor tissue / paraffin block |
7-14 days |
| 5 |
UGT1A1 |
İrrinotecan |
Peripheral blood (2 ml, EDTA ) |
7-14 days |
| 6 |
RRM1 |
Gemcitabine |
Tumor tissue / paraffin block |
7-14 days |
| 7 |
TUBB3 |
Taxanes, Vinorelbine, Paclitaxel |
Tumor tissue / paraffin block |
7-14 days |
| 8 |
TYMS |
Fluoropyrimidine (5-florouracil, capecitabine, tegafur) vəRaltitrexed, Pemetrexed, MTX, Thiopurines, Leucovorin |
Tumor tissue / paraffin block |
7-14 days |
| 9 |
ERCC1 |
Cisplatin,Carboplatin,Oxaliplatin |
Tumor tissue / paraffin block |
7-14 days |
| 10 |
DPYD*2A |
Drugs-Resistance to 5-FU |
Peripheral blood (2 ml, EDTA ) |
7-14 days |
| 11 |
MGMT(Methylation of promotor ) |
Procarbazine, Streptozotocin və Temozolomide |
Tumor tissue / paraffin block.Peripheral blood (2 ml, EDTA ) |
7-14 days |
